AI Proteins
PrivateLast Round
Series A
Nov 19, 2025
Total Funding Raised
$59.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AI Proteins is a biotechnology company that utilizes an artificial intelligence-based design and a high-throughput drug discovery platform to create synthetic miniproteins for a variety of therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AI Proteins Comparables
Compare AI Proteins with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nabla Bio | 89% | |
| Evozyne | 88% | |
| Profluent Bio | 86% |
AI Proteins Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 19, 2025 | ||||
| Seed | Nov 3, 2022 |
Key People
Founding team and executive leadership
AI Proteins Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Santé Ventures | Series A |
| Mission BioCapital | Series A |
| Santé Ventures | Series A |
| Cobro Ventures | Series A, Seed |
| Tachyon Ventures | Seed |
| LightChain Capital | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 78% MoM, reaching 7.7K.
- Nov 19, 2025
$42M round led by Mission BioCapital and Santé Ventures.
AI Proteins Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AI Proteins's valuation, stock price, and market status.
Is AI Proteins a public or private company?
AI Proteins is a private company.
What is the current stock price of AI Proteins?
AI Proteins is a private company with no public stock price. No recent secondary market data is available.
How much is AI Proteins worth (valuation)?
Valuation information for AI Proteins is not publicly available.
Can I buy AI Proteins stock?
AI Proteins shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AI Proteins's last funding round?
AI Proteins's most recent funding round was Series A on November 19, 2025.
Who are the main investors in AI Proteins?
Key investors in AI Proteins include Mission BioCapital, Santé Ventures, Cobro Ventures, LightChain Capital.
Will AI Proteins IPO soon?
No public IPO plans have been announced for AI Proteins.
How can I track AI Proteins secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AI Proteins's secondary market activity and sign up for updates.